Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

COVID-19 Risk Stratification

NCT04339387 is registered in ClinicalTrials.gov with Brigham and Women's Hospital as lead sponsor.

NCT NCT04339387
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04339387 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
COVID-19 Risk Stratification
Lead sponsor
Brigham and Women's Hospital
Phase
Observational
Overall status
Completed
Start date
March 1, 2020
Completion date
April 26, 2020
Enrollment
1,326 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

coronavirus, coronavirus sars-associated as cause of disease classified elsewhere